Has Dariam Cardentey Oliva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,326 in general payments to Dariam Cardentey Oliva, MD across 99 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dariam Cardentey Oliva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dariam Cardentey Oliva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dariam Cardentey Oliva, MD

Vascular Surgery · Riverview, FLNPI 1508210832

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.2%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Medtronic at 38.5% of the total. Reporting peaked in 2023 at $2,267 and has fallen 75.3% since, to $559 in 2025. That places this record below the midpoint for vascular surgery clinicians in FL, where the typical reported total is $6,364.

$7,326in general payments, 2019–2025

Across 99 payments — averaging $74.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Cook Incorporated$1K
Cook Medical LLC$567
W. L. Gore & Associates, Inc.$492
Philips North America LLC$456
Silk Road Medical, Inc.$359
plus $1K from 13 others

What the payments were for

Consulting fees$2503%
Grants$2,00027%
Travel & lodging$1,50621%
Food & beverage$3,46147%
Education$1091%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	24	$2,821
Cook Incorporated	2	$1,245
Cook Medical LLC	8	$567
W. L. Gore & Associates, Inc.	13	$492
Philips North America LLC	10	$456
Silk Road Medical, Inc.	4	$359
Inari Medical, Inc.	2	$258
Boston Scientific	13	$221
Imperative Care, Inc	2	$201
Endologix LLC	2	$179
Conmed Corporation	1	$113
Mimedx Group, Inc.	5	$99
Organogenesis Inc.	4	$93
Lemaitre Vascular, Inc.	3	$63
Penumbra, Inc.	2	$49
Neuros Medical, Inc.	1	$31
Integra Lifesciences Corporation	1	$27
Smith+Nephew	1	$26
BD	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ENDURANT IIS$2,000
Zenith$1,669
ENROUTE Transcarotid Neuroprotection System$309
ENROUTE Transcarotid Stent$309
CT THROMBECTOMY SYSTEM KIT$250
FLOWTRIEVER CATHETER, S$250
EXCLUDER Conformable AAA Endoprosthesis with Active Control$199
PRODIGY CATHETER$131
Lasers$129
IV Other$122
GORE TAG Thoracic Branch Endoprosthesis$109
Torus Stent Graft System$106
ENDOCROSS Device$106

How this compares

$7,326 in reported general payments places this provider in the 50th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$360,094

Medicare patients

235

Services billed

1,406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	15	$12,093
ClopidogrelClopidogrel Bisulfate	98	$619

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Riverview

Samuel TapperStuart$1.3M
Mariano ArosemenaBradenton$472K
Manuel Perez IzquierdoOrlando$302K
Erin MooreJacksonville$300K
Rajesh MalikNaples$237K
Charles BaileyTampa$162K
Joseph WasselleMelbourne$161K
Joseph RicottaDelray Beach$156K
Murray ShamesTampa$144K
K Dean ArnaoutakisTampa$115K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →